Wellbutrin SR is a prescription medication that belongs to the class of norepinephrine dopamine reuptake inhibitors. Its therapeutic purpose is to increase the availability of norepinephrine and dopamine to improve mood and focus. The drug works by blocking the reuptake of these neurotransmitters, allowing them to remain active longer in synaptic spaces. This mechanism enhances the signaling of norepinephrine and dopamine, which are involved in attention regulation and emotional stability. The sustained release formulation delivers a steady concentration of the active ingredient over approximately twelve hours. By maintaining consistent levels, the medication supports continuous symptom control without requiring multiple daily doses. Clinically this leads to reduced depressive symptoms and improved concentration for patients with major depressive disorder or seasonal affective disorder.

Wellbutrin SR is an extended-release formulation of bupropion used to treat depression and to help prevent seasonal affective disorder. It works by increasing the levels of norepinephrine and dopamine in the brain through inhibition of their reuptake. The elevated neurotransmitters enhance mood regulation and improve energy and motivation. The extended-release design allows a steady release of the drug over 24 hours maintaining consistent blood concentrations. This prolonged exposure supports sustained antidepressant effects without the need for multiple daily doses. By modulating these key pathways the medication helps restore balance in mood circuits and reduces the symptoms of depressive episodes. The combined actions of neurotransmitter elevation and steady delivery produce the therapeutic outcome observed clinically.

Wellbutrin SR may cause insomnia or difficulty sleeping. Some users report dry mouth or a metallic taste. Weight loss or decreased appetite can occur in certain individuals. Headaches and dizziness are also reported side effects. In rare cases, the medication may increase anxiety or agitation. A small number of people experience seizures, especially at higher doses. These effects are generally mild to moderate and vary among users.

Some people experience insomnia or difficulty sleeping while taking Wellbutrin SR. Others may notice a dry mouth or an increase in thirst. Headaches are another frequently reported symptom of the medication. Feelings of agitation or restlessness can occur especially when the dose is high. In rare cases seizures have been documented in patients with predisposing risk factors. Weight loss is sometimes observed as an appetite suppressing effect. Occasionally vivid dreams or nightmares may be experienced.